<?xml version="1.0" encoding="UTF-8"?>
<p>To investigate if ISG expression has an antiviral effect on SLEV infection, we selected RIG-I (also known as DDX58) for in vitro experiments, since RIG-I was previously associated with protection against infection with flaviviruses [
 <xref rid="cit0036" ref-type="bibr">36</xref>]. Human RIG-I with constitutive antiviral activity was transiently expressed in HEK293T cells, which were infected with SLEV. HEK293T cells transfected with an empty vector (FLAGƟ) were used as control (
 <xref ref-type="fig" rid="f0002">Figure 2g-i</xref>). We observed that cells expressing human RIG-I had reduced SLEV titers in cell culture supernatants when compared to FLAGƟ controls, up to 10-fold at 48 h p.i. (
 <xref ref-type="fig" rid="f0002">Figure 2g</xref>). Analysis of cell culture lysates by Western Blot confirmed the expression of human RIG-I in transfected cells in both timepoints evaluated (
 <xref ref-type="fig" rid="f0002">Figure 2i</xref>).
</p>
